Wildcat Capital Management, LLC 13F holdings, Q2 2026
Holdings as of June 30, 2026 · filings on SEC EDGAR · this is the latest filing on record
Wildcat Capital Management, LLC disclosed 3 US equity positions worth $228.5m in its Q2 2026 13F filing. The largest position was ULCC at 97.1% of the reported book, followed by ALLO and CHYM. Against the Q1 2026 filing, it opened 1 new position, added to 0 and reduced 0 among the top 3 holdings.
What did Wildcat Capital Management, LLC own in Q2 2026? Top 3 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2026 |
|---|---|---|---|---|---|---|---|
| 1 | ULCC FRONTIER GROUP HLDGS INC | Industrials | 97.1% | $222.0m | 28,061,351 | 0% | held |
| 2 | ALLO ALLOGENE THERAPEUTICS INC | Healthcare | 2.7% | $6.1m | 2,920,787 | 0% | held |
| 3 | CHYM CHIME FINL INC | Technology | 0.2% | $488.9k | 23,874 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.